Exchange transfusion as an adjunct to the treatment of severe falciparum malaria: case report and review.

Malaria associated with complications or a fatal outcome is almost always caused by Plasmodium falciparum. The mortality due to this disease parallels the degree of parasitemia. Successful use of exchange blood transfusion as a therapeutic adjunct for this infection was first reported in 1974, although the efficacy of this procedure has not been established by randomized, controlled trials. The rationale for this form of therapy is based on: (1) rapid reduction in the parasite load by direct removal; (2) decreased risk of severe intravascular hemolysis and its consequences (disseminated intravascular coagulation and renal dysfunction); (3) improved rheology with transfused blood and reduced microcirculatory sludging; and (4) improved oxygen-carrying capacity with transfused erythrocytes. We describe a case of severe falciparum malaria and review the literature describing the use of exchange transfusion for treatment of this infection.

[1]  Clark,et al.  Possible importance of macrophage-derived mediators in acute malaria , 1981, Infection and immunity.

[2]  P. Chiodini,et al.  Exchange transfusion in severe falciparum malaria. , 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[3]  G. Cook.  PREVENTION AND TREATMENT OF MALARIA , 1988, The Lancet.

[4]  I. Clark,et al.  IMMUNITY TO INTRA-ERYTHROCYTIC PROTOZA , 1975, The Lancet.

[5]  N. White,et al.  Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. , 1985, The New England journal of medicine.

[6]  F. Morrison,et al.  Automated erythrocyte exchange in fulminant falciparum malaria. , 1984, Annals of internal medicine.

[7]  O. Martino,et al.  Therapeutic use of exchange transfusion in malaria. , 1979, The American journal of tropical medicine and hygiene.

[8]  K. Miller,et al.  Continuous-infusion quinidine gluconate for treating children with severe Plasmodium falciparum malaria. , 1987, The Journal of infectious diseases.

[9]  G. Raman,et al.  Loa loa: the use of a blood cell separator to reduce microfilaraemia before specific chemotherapy. , 1984, The Journal of infection.

[10]  W. Trager,et al.  Fine structure of human malaria in vitro. , 1978, The Journal of protozoology.

[11]  J. W. Field.  Blood examination and prognosis in acute falciparum malaria. , 1949, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[12]  C. Gilks,et al.  STRATEGIES FOR THE PREVENTION OF MALARIA IN TRAVELLERS: COMPARISON OF DRUG REGIMENS BY MEANS OF RISK-BENEFIT ANALYSIS , 1986, The Lancet.

[13]  K. Miller,et al.  Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. , 1989, The New England journal of medicine.

[14]  H. Lee,et al.  Usefulness of apheresis to extract microfilarias in the management of loiasis. , 1983, British medical journal.

[15]  C. C. Campbell,et al.  Fulminant Plasmodium falciparum infection treated with exchange blood transfusion. , 1983, Journal of the American Medical Association (JAMA).

[16]  P. Dellamonica,et al.  [Acute respiratory distress syndrome with fatal outcome after exsanguinotransfusion in pernicious malaria attack]. , 1989, Presse medicale.

[17]  D. Warhurst,et al.  Exchange transfusion in falciparum malaria , 1990, The Lancet.

[18]  F. Luft,et al.  The use of exchange transfusions: a potentially useful adjunct in the treatment of fulminant falciparum malaria. , 1979, The American journal of the medical sciences.

[19]  A. Hall,et al.  Exchange transfusion and quinine concentrations in falciparum malaria. , 1985, British medical journal.

[20]  R. Kahn,et al.  Post-transfusion Hepatitis: Current Perspectives , 1980 .

[21]  L. Miller,et al.  Falciparum malaria-infected erythrocytes specifically bind to cultured human endothelial cells. , 1981, Science.

[22]  V. Bennett,et al.  Plasmodium falciparum malaria: band 3 as a possible receptor during invasion of human erythrocytes. , 1985, Science.

[23]  S. Phanichphant,et al.  Exchange transfusion in cerebral malaria complicated by disseminated intravascular coagulation. , 1979, The Southeast Asian journal of tropical medicine and public health.

[24]  J. Nosanchuk,et al.  Transfusion malaria: treatment with exchange transfusion after delayed diagnosis. , 1982, Archives of internal medicine.

[25]  B. Maegraith.  Blackwater fever anuria , 1944 .

[26]  K. Miller,et al.  Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations. , 1988, The New England journal of medicine.

[27]  J. Keystone,et al.  The changing pattern of imported malaria. , 1988, Canada diseases weekly report = Rapport hebdomadaire des maladies au Canada.

[28]  Gary K. Matsuura,et al.  Ineffectiveness of Continuous Quinidine Gluconate Infusion in the Treatment of Severe Chloroquine-Resistant Plasmodium Falciparum Malaria , 1988, Drug Intelligence & Clinical Pharmacy.

[29]  F. Carpentier,et al.  Accès pernicieux palustre. Evolution rapidement favorable après exsanguino-transfusion. , 1986 .